Immunology Deals and Alliances of 2014 - Worldwide Industry size, share, trend, growth, analysis and Research Report

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

The Immunology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.

To Download Sample Report With TOC: http://www.researchmoz.com/enquiry.php?type=sample&repid=264348

Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.

The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.

Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication.

To Browse a Full Report with TOC: http://www.researchmoz.us/immunology-deals-and-alliances-of-2014-report.html

Chapter 2 provides a comprehensive listing of deals by average headline, upfront, milestone and royalty rate payments

Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by most active dealmakers, top deals by value, big pharma and big biotech activity, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a comprehensive directory of all partnering deals announced during 2014. The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in partnering and dealmaking during 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.

All Reports of this Category Here: http://www.researchmoz.us/therapeutic-area-market-reports-37.html


About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:


Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030

Inflammatory Bowel Disease Partnering 2010-2015 - Worldwide Industry size, share, trend, growth, analysis and Research Report

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

The Inflammatory Bowel Disease Partnering 2010-2015 report provides understanding and access to the inflammatory bowel disease partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in inflammatory bowel disease partnering deals
Top inflammatory bowel disease deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

To Download Sample Report With TOC: http://www.researchmoz.com/enquiry.php?type=sample&repid=263433

The Inflammatory Bowel Disease Partnering 2010-2015 provides understanding and access to the inflammatory bowel disease partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of inflammatory bowel disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors inflammatory bowel disease technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains over 50 links to online copies of actual inflammatory bowel disease deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of inflammatory bowel disease partnering trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 3 provides an overview of the average deal terms since 2010. The chapter includes deals with a stage of development announced by headline value, upfront value, milestone value and royalty rate. Numerous tables outline financial trends.

Chapter 4 provides an overview of the most active dealmakers, top dealmakers by value, active big pharma and big biotech dealmakers including contract documents where available.

To Browse a Full Report with TOC: http://www.researchmoz.us/inflammatory-bowel-disease-partnering-2010-2015-report.html

Chapter 5 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of inflammatory bowel disease technologies and products.

Report scope

Inflammatory Bowel Disease Partnering 2010-2015 is intended to provide the reader with an in-depth understanding and access to inflammatory bowel disease trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:

Trends in inflammatory bowel disease dealmaking in the biopharma industry since 2010
Access to summary headline, upfront, milestone and royalty data
Access to over 50 inflammatory bowel disease deals
The leading inflammatory bowel disease deals by value since 2010

In Inflammatory Bowel Disease Partnering 2010-2015, the available deals are listed by:

Headline value
Upfront payment value
Royalty rate value
Company A-Z
Industry sector
Stage of development at signing
Deal component type
Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

All Reports of this Category Here: http://www.researchmoz.us/pharmaceutical-market-reports-38.html


About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:


Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030

Sexual Health Deals and Alliances of 2014 - Worldwide Industry size, share, trend, growth, analysis and Research Report

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

The Sexual Health Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.

To Download Sample Report With TOC: http://www.researchmoz.com/enquiry.php?type=sample&repid=264270

Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.

The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.

Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication.

To Browse a Full Report with TOC: http://www.researchmoz.us/sexual-health-deals-and-alliances-of-2014-report.html

Chapter 2 provides a comprehensive listing of deals by average headline, upfront, milestone and royalty rate payments

Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by most active dealmakers, top deals by value, big pharma and big biotech activity, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a comprehensive directory of all partnering deals announced during 2014. The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in partnering and dealmaking during 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.

All Reports of this Category Here: http://www.researchmoz.us/therapeutic-area-market-reports-37.html


About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:


Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030

Non-Small Cell Lung Cancer Partnering 2010-2015 - Worldwide Industry size, share, trend, growth, analysis and Research Report

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

The Non-Small Cell Lung Cancer Partnering 2010-2015 report provides understanding and access to the non-small cell lung cancer partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in non-small cell lung cancer partnering deals
Top non-small cell lung cancer deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

To Download Sample Report With TOC: http://www.researchmoz.com/enquiry.php?type=sample&repid=264378

The Non-Small Cell Lung Cancer Partnering 2010-2015 provides understanding and access to the non-small cell lung cancer partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of non-small cell lung cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors non-small cell lung cancer technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

To Browse a Full Report with TOC: http://www.researchmoz.us/non-small-cell-lung-cancer-partnering-2010-2015-report.html

This data driven report contains over 60 links to online copies of actual non-small cell lung cancer deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of non-small cell lung cancer partnering trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 3 provides an overview of the average deal terms since 2010. The chapter includes deals with a stage of development announced by headline value, upfront value, milestone value and royalty rate. Numerous tables outline financial trends.

Chapter 4 provides an overview of the most active dealmakers, top dealmakers by value, active big pharma and big biotech dealmakers including contract documents where available.

Chapter 5 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of non-small cell lung cancer technologies and products.

Report scope

Non-Small Cell Lung Cancer Partnering 2010-2015 is intended to provide the reader with an in-depth understanding and access to non-small cell lung cancer trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:

Trends in non-small cell lung cancer dealmaking in the biopharma industry since 2010
Access to summary headline, upfront, milestone and royalty data
Access to over 60 non-small cell lung cancer deals and contract documents where available
The leading non-small cell lung cancer deals by value since 2010

In Non-Small Cell Lung Cancer Partnering 2010-2015, the available deals are listed by:

Headline value
Upfront payment value
Royalty rate value
Company A-Z
Industry sector
Stage of development at signing
Deal component type
Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.


All Reports of this Category Here: http://www.researchmoz.us/diseases-conditions-market-reports-67.html


About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:


Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030

Metabolic Deals and Alliances of 2014 - Worldwide Industry size, share, trend, growth, analysis and Research Report

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

The Metabolic Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.

Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.

To Download Sample Report With TOC: http://www.researchmoz.com/enquiry.php?type=sample&repid=264345

The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.

Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication.

Chapter 2 provides a comprehensive listing of deals by average headline, upfront, milestone and royalty rate payments

Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by most active dealmakers, top deals by value, big pharma and big biotech activity, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a comprehensive directory of all partnering deals announced during 2014. The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in partnering and dealmaking during 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.

To Browse a Full Report with TOC: http://www.researchmoz.us/metabolic-deals-and-alliances-of-2014-report.html

Executive Summary

Introduction

Chapter 1 – Trends in dealmaking during 2014
1.1 Introduction
1.2. Partnering by deal type
1.3. Partnering by industry sector
1.4. Partnering by stage of development
1.5. Partnering by technology type
1.6. Partnering by therapy area

Chapter 2 – Average financial deal terms
2.1 Partnering deals with headline values
2.2 Partnering deals with upfront payments
2.3 Partnering deals with milestone payments
2.4 Partnering deals withroyalty rates

Chapter 3 – Leading deals during 2014
3.1. Introduction
3.2. Most active dealmakers
3.3. Top deals by value during 2014
3.4. Big pharma dealmaking activity
3.5. Big biotech dealmaking activity

Chapter 4 – Partnering deals directory 2014
4.1. Introduction
4.2. Company A-Z
4.3. By deal type
4.4. By stage of development
4.5. By technology type
4.6. By therapy area

All Reports of this Category Here: http://www.researchmoz.us/therapeutic-area-market-reports-37.html


About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:


Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030

Vaccine Deals and Alliances of 2014 - Worldwide Industry size, share, trend, growth, analysis and Research Report

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

The Vaccine Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.

To Download Sample Report With TOC: http://www.researchmoz.com/enquiry.php?type=sample&repid=264255

Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.

The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.

Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication.

To Browse a Full Report with TOC: http://www.researchmoz.us/vaccine-deals-and-alliances-of-2014-report.html

Chapter 2 provides a comprehensive listing of leading deals by deal values, most active dealmakers, big pharma and big biotech deal activity.

Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by big pharma company profiles, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a comprehensive listing of leading deals of 2014 listed by big biotech company profiles, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 5 provides a comprehensive directory of all partnering deals announced during 2014.
The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in partnering and dealmaking during 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.


All Reports of this Category Here: http://www.researchmoz.us/vaccines-market-reports-79.html


About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:


Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030

Oncology Deals and Alliances of 2014 - Worldwide Industry size, share, trend, growth, analysis and Research Report

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

The Oncology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.

To Download Sample Report With TOC: http://www.researchmoz.com/enquiry.php?type=sample&repid=264294

Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.

The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.

Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication.

To Browse a Full Report with TOC: http://www.researchmoz.us/oncology-deals-and-alliances-of-2014-report.html

Chapter 2 provides a comprehensive listing of deals by average headline, upfront, milestone and royalty rate payments

Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by most active dealmakers, top deals by value, big pharma and big biotech activity, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a comprehensive directory of all partnering deals announced during 2014. The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in partnering and dealmaking during 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.


All Reports of this Category Here: http://www.researchmoz.us/oncology-market-reports-108.html


About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:


Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030